Mechanistically, the up-regulation of MHC molecules on the cancer cell surface upon treatment with CDK4/6 inhibitors was correlated with the immune surveillance-promoting effects of the interferon signalling [137, 148, 153, 154]. This evidence concerns the gene HLA-C and cancer.